Patent classifications
A61K33/38
Electro-conductive and anti-bacterial composite material, for endodontic use
A gutta-percha-silver composite with determined weight percentage and particle size, is provided. The composite exhibits electro-conductivity greater than the standard gutta-percha composites. The new material simplifies root canal treatments, shortens the times both for clinician and patients, and reduces the exposure to patients from X-rays. The material is not only electro-conductive; it is anti-bacterial, which improves the outcomes of the procedures. Also, it has improved thermal conductivity, and mechanical properties.
Electro-conductive and anti-bacterial composite material, for endodontic use
A gutta-percha-silver composite with determined weight percentage and particle size, is provided. The composite exhibits electro-conductivity greater than the standard gutta-percha composites. The new material simplifies root canal treatments, shortens the times both for clinician and patients, and reduces the exposure to patients from X-rays. The material is not only electro-conductive; it is anti-bacterial, which improves the outcomes of the procedures. Also, it has improved thermal conductivity, and mechanical properties.
PORUS SILICA-CONTAINING NANOPARTICLES, PRODUCTION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSTION FOR RADIATION TREATMENT
The present invention provides: nanoparticles including a compound that includes porous silica and at least one high-atom selected from the group consisting of gadolinium atoms, iodine atoms, gold atoms, silver atoms, and platinum atoms; and a pharmaceutical composition for radiation treatment, useful for treatment of solid tumors, etc., and including these nanoparticles and a pharmaceutically acceptable carrier.
PORUS SILICA-CONTAINING NANOPARTICLES, PRODUCTION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSTION FOR RADIATION TREATMENT
The present invention provides: nanoparticles including a compound that includes porous silica and at least one high-atom selected from the group consisting of gadolinium atoms, iodine atoms, gold atoms, silver atoms, and platinum atoms; and a pharmaceutical composition for radiation treatment, useful for treatment of solid tumors, etc., and including these nanoparticles and a pharmaceutically acceptable carrier.
DISILVER HYDROGEN CITRATE-CONTAINING COMPOSITION, METHOD FOR PRODUCING SAME, ANTIBACTERIAL AGENT OR ANTIVIRAL AGENT USING SAME, AND METHOD FOR PRODUCING SAME
Provided are powder of a pure disilver hydrogen citrate-containing composition in powder form, having excellent solubility, and a method for easily obtaining the disilver hydrogen citrate-containing composition with high efficiency. In addition, provided are an antibacterial agent or antiviral agent, containing the disilver hydrogen citrate-containing composition, and a method for producing the same.
The method for producing a disilver hydrogen citrate-containing composition of the present invention includes the following processes (1) to (3): (1) preparing a reaction mixture containing a silver compound and citric acid, the reaction mixture having a pH of 2.0 to 5.5; (2) precipitating the disilver hydrogen citrate-containing composition from the reaction mixture; and (3) collecting the precipitated disilver hydrogen citrate-containing composition.
Synthesis of nanoparticle in liquid, semi-solid media and in cells and tissues using cold plasma technology
A method of forming metal nanoparticles includes applying a substance to an area of interest, applying cold plasma to the area of interest, and synthesizing nanoparticles from the substance using the cold plasma in the area of interest, wherein the substance is a solution that contains metal ions, and the nanoparticles synthesized are metallic in nature.
Synthesis of nanoparticle in liquid, semi-solid media and in cells and tissues using cold plasma technology
A method of forming metal nanoparticles includes applying a substance to an area of interest, applying cold plasma to the area of interest, and synthesizing nanoparticles from the substance using the cold plasma in the area of interest, wherein the substance is a solution that contains metal ions, and the nanoparticles synthesized are metallic in nature.
Synthesis of nanoparticle in liquid, semi-solid media and in cells and tissues using cold plasma technology
A method of forming metal nanoparticles includes applying a substance to an area of interest, applying cold plasma to the area of interest, and synthesizing nanoparticles from the substance using the cold plasma in the area of interest, wherein the substance is a solution that contains metal ions, and the nanoparticles synthesized are metallic in nature.
ANTIMICROBIAL SHOE INSOLE AND USE THEREOF
The present invention is directed to an antimicrobial shoe insole comprising an antimicrobial composition. The antimicrobial shoe insole has the density from 0.12 to 0.30 g/cm.sup.3, preferably 0.18 to 0.22 g/cm.sup.3, the hardness of the shore C is 28 to 45, the ball rebound rate is ≥65%, and anti-fatigue test (20% compression rate) is over 10,000 times. The antimicrobial shoe insole is formulated to have a sterilization rate over 99.99%, durable, and the mildew resistance index can be zero with no detectable mildew growth.
ANTIMICROBIAL SHOE INSOLE AND USE THEREOF
The present invention is directed to an antimicrobial shoe insole comprising an antimicrobial composition. The antimicrobial shoe insole has the density from 0.12 to 0.30 g/cm.sup.3, preferably 0.18 to 0.22 g/cm.sup.3, the hardness of the shore C is 28 to 45, the ball rebound rate is ≥65%, and anti-fatigue test (20% compression rate) is over 10,000 times. The antimicrobial shoe insole is formulated to have a sterilization rate over 99.99%, durable, and the mildew resistance index can be zero with no detectable mildew growth.